Keywords: Amgen, Financial results, Second-quarter 2012

Amgen beats expectations as 2nd-qtr revenues rise 13% and EPS grows 34%

Article | 27 July 2012

Print This

The world’s largest independent biotech company, USA-based Amgen (Nasdaq: AMGN), saw its shares move higher in after-hours trading ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in